AFPT - Club Phase 1 webinar: Dose optimization in Oncology
Dose optimization in oncology drug development is at the heart of the recent US FDA’s project Optimus initiative, to better satisfy the benefit:risk ratio for the patients as early as possible.
A new paradigm is emerging.
Join us for an insightful webinar with 2 expert speakers, Gu Mi , Ph D (Biostatistics) and Laurent Nguyen, Pharm D, Ph D (Clinical PK and pharmacometrics), involved in oncology drug development.
______________________________________________________________________
Become a member of the AFPT - Club Phase 1 association to benefit freely from our webinars. Register as a member on the website of AFPT – Club Phase 1 and participate to the webinar for free after payment of your membership.